Detection, evaluation, and treatment of severe and resistant hypertension
- 1 October 2014
- journal article
- review article
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 8 (10) , 743-757
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- National Institute on Drug Abuse
- Medtronic
This publication has 81 references indexed in Scilit:
- Prevalence of Optimal Treatment Regimens in Patients With Apparent Treatment-Resistant Hypertension Based on Office Blood Pressure in a Community-Based Practice NetworkHypertension, 2013
- Renal Sympathetic Denervation in Patients With Treatment-Resistant Hypertension After Witnessed Intake of Medication Before Qualifying Ambulatory Blood PressureHypertension, 2013
- Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant HypertensionCirculation, 2013
- Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trialEuropean Heart Journal, 2013
- Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheterEuropean Heart Journal, 2013
- Azilsartan Medoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic HypertensionHypertension, 2012
- Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New DevelopmentsCardiology Research and Practice, 2012
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008Circulation, 2011
- Chronic Lowering of Blood Pressure by Carotid Baroreflex ActivationHypertension, 2011
- Carotid Baroreflex Activation: Past, Present, and FutureCurrent Hypertension Reports, 2010